The latest health news highlights FDA's approval of BridgeBio's drug for a rare heart condition, cancer features in healthy ...
If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. To calculate this metric for Ypsomed Holding, this is the ...
Now, a partnership between Ypsomed and Sidekick Heath aims to tackle that problem. Ypsomed is a top developer of injection and infusion systems, so knows a lot about the difficulties that patients ...
Becton, Dickinson and Company announced a strategic collaboration with Ypsomed, a developer of injection systems, to advance self-injection solutions for high-viscosity biologic drugs.
Ypsomed Holding (SWX:YPSN) has recently announced a strategic partnership with Astria Therapeutics to develop an autoinjector for STAR-0215, underscoring its commitment to innovation and enhancing ...
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through ...
Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish drugmaker's next-generation experimental obesity drug CagriSema, a source ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback